PMCTPharmaCountry
    Accueil

Analyse

Analyses approfondies des marchés pharmaceutiques, des chaînes d'approvisionnement, de la technologie et de la réglementation

#4615 ×

Analyse
21 sept. 2026•1 min de lecture
BaroPharm Submits Securities Filing, Begins KOSDAQ IPO Process
BaroPharm filed a securities report with the Financial Services Commission and announced a public offering of 1.78 million shares, targeting a 16,400‑22,200 KRW price range, aiming for a KOSDAQ listing this year.